Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
24 results
D2.03 - A Rare Case of Thyme Allergy in a Pediatric Patient: First Report and Clinical Insights
D2.04 - Sensitization to common food allergens in a population of portuguese children
D2.05 - A Retrospective Study Characterising the Types of Presentation of Soy Allergy in Adults
D2.06 - Peanut allergy diagnosis. Our experience
D2.08 - Post-Traumatic Stress Disorder Associated with Anaphylaxis
D2.09 - Correlation Patterns Among House Dust Mite Allergens in Allergic Rhinitis: A Molecular Sensitization Study in Mallorca
D2.10 - Can specific IgE components for egg allergy - predict egg ladder success?
D2.11 - A confidence score for basophil activation test: improving interpretation around diagnostic cutoffs
D2.12 - Indirect Basophil Activation Test: development of a user-friendly protocol for plasma and allergen testing
D2.13 - Structural Homology of Alt a 1 and Phl p 2 Suggests an explanation for coincidence of Grass and Alternaria Allergies
D2.15 - The etiology and risk factors of food allergies in children in Albania
D2.16 - Clinical evaluation of the efficacy of profilin isolated from Acanthamoeba as an allergen
D2.351 - Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria
D2.352 - Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria
D2.353 - A Single Dose of Briquilimab, An Anti-Human CD117 (c-Kit) Antibody, Protects Against Relapse of Epicutaneous Allergen-Induced Dermatitis in Mice Expressing Chimeric Human/Mouse CD117
D2.354 - Questionnaire survey of new treatments for atopic dermatitis
D2.355 - Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria
D2.356 - Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria
D2.357 - Characterizing chronic histaminergic angioedema and chronic urticaria with angioedema, a multicenter Italian experience
D2.358 - Immune shift toward the IL-17 pathway: A case of paradoxical psoriasis in a patient with severe atopic dermatitis induced by dupilumab
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download